BPG is committed to discovery and dissemination of knowledge
Citation
Kaito A, Kuwata T, Tokunaga M, Shitara K, Sato R, Akimoto T, Kinoshita T. Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977). World J Clin Cases 2020; 8(21): 5494-5495 [PMID: 33269289 DOI: 10.12998/wjcc.v8.i21.5494]
Please LOGIN to submit a new comment.